Komori
StemCell Institute (7096) · InitiativeCited as achieved

Securing financing through a listing and expanding the business

First written in FY2021. 2 of 5 entries say "Cited as achieved", first in FY2022-Q2. Latest entry: FY2023-Q1.

5entries
2years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAchievedFY2022-Q1Cited as achievedFY2022-Q22021: 320212022: 22022
Same theme, other companies
Tokyo Stock Exchange Mothers Listing and Public OfferingA theme 64 companies write about · 0 as a headwind · 64 as a tailwind

The whole theme swung hardest in 2022: 12 of 48 companies on the "Worse" side.

8 other companies' latest entry also says "Cited as achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 64 companies compared. The sentences above are computed from all 64.
Moved together

"Increase in the Annual Number of Stored Specimens and Improvement in the Equity Ratio" moved the same way as this thread, in the same document, in 2 of its 5 moves.

222★123
  1. ★This thread
  2. 1Increase in the Annual Number of Stored Specimens and Improvement in the Equity Ratio2×
  3. 2Launch of Umbilical Cord Tissue Storage Service2×
  4. 3Expansion of Cell Processing and Storage Capacity2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for StemCell Institute yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.